Top Stories of 2022
Top Stories of 2022
Revisit some of Gladstone’s most important stories from the past year
Gladstone Experts Cardiovascular Disease Data Science and Biotechnology Genomic Immunology Neurological Disease Virology16 - 30 of 84 Results Clear All
Revisit some of Gladstone’s most important stories from the past year
Gladstone Experts Cardiovascular Disease Data Science and Biotechnology Genomic Immunology Neurological Disease VirologyFor World Alzheimer’s Month, researchers talk about their work and hopes of finding new treatments for this debilitating disease
Alzheimer’s Disease Neurological DiseaseStudy suggests that targeting a protein in the thalamus could block the long-term damage that follows brain injuries
News Release Research (Publication) Traumatic Brain Injury Neurological Disease Paz LabGladstone scientists show that reducing levels of the protein tau soon after birth can prevent these conditions in an experimental model
News Release Research (Publication) Epilepsy Neurological Disease Mucke Lababc7 news—Senior Investigator Katerina Akassoglou, PhD, commenting on two recent studies that show long-term neurological symptoms in some COVID-19 patients, suggests that these symptoms could result from blood leaks into the brain, which can happen even during a minor infection.
Gladstone Experts COVID-19 Neurological Disease Akassoglou LabGladstone investigator receives distinct honor within the scientific community
Awards News Release Neurological Disease Akassoglou LabThe Conversation—Individuals who survive traumatic brain injury can suffer from life-long complications, such as cognitive deficits, seizures, and sleep disruption. Jeanne Paz, PhD, describes her work in mice showing that treatment with an antibody that blocks an element of immune system activation may be able to prevent such consequences.
Gladstone Experts Traumatic Brain Injury Neurological Disease Paz LabBioIT World—Despite decades of research, medical therapies for Alzheimer’s disease have so far proven elusive. Senior Investigator Yadong Huang describes how his innovative approach to drug repurposing has identified a promising candidate drug that is now moving toward clinical trials.
Gladstone Experts Alzheimer’s Disease Neurological Disease Huang LabABC News—Traumatic brain injuries can result in sleep disruptions and seizures. Gladstone Associate Investigator Jeanne Paz describes her team’s recent identification of an immune molecule that may be key to these symptoms, and the potential to treat brain injury survivors with new therapies.
Gladstone Experts Traumatic Brain Injury Neurological Disease Paz LabGladstone scientists identified treatments to block subtle epileptic activity and chronic brain inflammation in a mouse model of Alzheimer’s disease
News Release Research (Publication) Alzheimer’s Disease Neurological Disease Mucke LabGladstone scientists help explain how reducing the protein tau can prevent abnormal brain activity associated with Alzheimer’s disease, autism, and epilepsy
News Release Research (Publication) Alzheimer’s Disease Epilepsy Neurological Disease Mucke LabLennart Mucke is recognized for his pioneering discoveries in research on Alzheimer’s disease and related disorders
Awards News Release Neurological Disease Mucke LabSmithsonian Magazine—Associate Investigator Jeanne Paz, PhD, discusses her lab's recent discovery that C1q, a component of the immune system, mediates cognitive deficits after a traumatic brain injury and may lead to new ways to curb or prevent these deficits.
Gladstone Experts Traumatic Brain Injury Epilepsy Neurological Disease Paz LabStudy points to a potential new treatment that could prevent chronic complications
News Release Research (Publication) Traumatic Brain Injury Neurological Disease Paz LabStudy points to a new promising therapy against toxic blood leaks in the brain
News Release Research (Publication) Alzheimer’s Disease Center for Neurovascular Brain Immunology Neurological Disease Akassoglou Lab